PortfoliosLab logoPortfoliosLab logo
TGTX vs. ARIS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TGTX vs. ARIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TG Therapeutics, Inc. (TGTX) and Aris Water Solutions, Inc. (ARIS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TGTX achieves a 74.54% return, which is significantly higher than ARIS's -17.68% return.


TGTX

1D
-2.80%
1M
-2.78%
6M
76.79%
YTD
74.54%
1Y
46.56%
3Y*
70.54%
5Y*
8.26%
10Y*
24.71%
ALL TIME*
-7.87%

ARIS

1D
-6.25%
1M
-8.62%
6M
-22.05%
YTD
-17.68%
1Y
92.23%
3Y*
76.24%
5Y*
10Y*
ALL TIME*
28.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$19.88M$21.50M$22.93M
$111.05M$115.82M$119.77M

TGTX vs. ARIS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TGTX
TG Therapeutics, Inc.
74.54%-0.96%76.23%44.38%-37.74%-40.27%
ARIS
Aris Water Solutions, Inc.
-17.68%363.71%6.54%31.93%-39.60%1.33%

Correlation

The correlation between TGTX and ARIS is 0.15, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.15

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (All Time)
Calculated using the full available price history since Oct 22, 2021

0.11

Fundamentals

Market Cap

TGTX:

$7.96B

ARIS:

$2.76B

EPS

TGTX:

$2.88

ARIS:

$1.37

PE Ratio

TGTX:

18.04

ARIS:

9.75

PEG Ratio

TGTX:

0.03

ARIS:

0.19

PS Ratio

TGTX:

11.90

ARIS:

2.18

PB Ratio

TGTX:

14.28

ARIS:

1.59

Total Revenue (TTM)

TGTX:

$700.35M

ARIS:

$1.26B

Gross Profit (TTM)

TGTX:

$581.54M

ARIS:

$677.96M

EBITDA (TTM)

TGTX:

$156.88M

ARIS:

$584.28M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TGTX vs. ARIS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TGTX
TGTX Risk / Return Rank: 7474
Overall Rank
TGTX Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 7373
Sortino Ratio Rank
TGTX Omega Ratio Rank: 7373
Omega Ratio Rank
TGTX Calmar Ratio Rank: 7777
Calmar Ratio Rank
TGTX Martin Ratio Rank: 7373
Martin Ratio Rank

ARIS
ARIS Risk / Return Rank: 8585
Overall Rank
ARIS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ARIS Sortino Ratio Rank: 8282
Sortino Ratio Rank
ARIS Omega Ratio Rank: 8383
Omega Ratio Rank
ARIS Calmar Ratio Rank: 8686
Calmar Ratio Rank
ARIS Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TGTX vs. ARIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TG Therapeutics, Inc. (TGTX) and Aris Water Solutions, Inc. (ARIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TGTXARISDifference
Sharpe ratioReturn per unit of total volatility

-0.80

Sortino ratioReturn per unit of downside risk

-0.52

Omega ratioGain probability vs. loss probability

1.21

1.29

-0.08

Calmar ratioReturn relative to maximum drawdown

1.74

2.91

-1.17

Martin ratioReturn relative to average drawdown

3.46

7.16

-3.70

TGTX vs. ARIS - Sharpe Ratio Comparison

The current TGTX Sharpe Ratio is 0.99, which is lower than the ARIS Sharpe Ratio of 1.80. The chart below compares the historical Sharpe Ratios of TGTX and ARIS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TGTX vs. ARIS - Drawdown Comparison

The maximum TGTX drawdown since its inception was -99.52%, which is greater than ARIS's maximum drawdown of -57.98%. Use the drawdown chart below to compare losses from any high point for TGTX and ARIS.


Loading charts...

Drawdown Indicators


TGTXARISDifference

Max Drawdown

Largest peak-to-trough decline

-99.52%

-57.98%

-41.54%

Max Drawdown (1Y)

Largest decline over 1 year

-26.85%

-38.29%

+11.44%

Max Drawdown (3Y)

Largest decline over 3 years

-42.06%

-38.29%

-3.77%

Max Drawdown (5Y)

Largest decline over 5 years

-89.47%

Max Drawdown (10Y)

Largest decline over 10 years

-93.19%

Current Drawdown

Current decline from peak

-77.71%

-38.29%

-39.42%

Average Drawdown

Average peak-to-trough decline

-91.31%

-22.90%

-68.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.66%

14.58%

-0.92%

Volatility

TGTX vs. ARIS - Volatility Comparison

The current volatility for TG Therapeutics, Inc. (TGTX) is 12.23%, while Aris Water Solutions, Inc. (ARIS) has a volatility of 19.50%. This indicates that TGTX experiences smaller price fluctuations and is considered to be less risky than ARIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TGTXARISDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.23%

19.50%

-7.27%

Volatility (6M)

Calculated over the trailing 6-month period

33.96%

47.43%

-13.47%

Volatility (1Y)

Calculated over the trailing 1-year period

47.22%

62.04%

-14.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.68%

53.44%

+34.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

86.71%

53.44%

+33.27%

Dividends

TGTX vs. ARIS - Dividend Comparison

Neither TGTX nor ARIS has paid dividends to shareholders.


PositionTTM20252024202320222021
ARIS
Aris Water Solutions, Inc.
0.00%0.00%0.00%0.00%3.84%0.85%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TGTX vs. ARIS - Financials Comparison

This section allows you to compare key financial metrics between TG Therapeutics, Inc. and Aris Water Solutions, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

TGTX vs. ARIS - Profitability Comparison

The chart below illustrates the profitability comparison between TG Therapeutics, Inc. and Aris Water Solutions, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

ARIS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Aris Water Solutions, Inc. reported a gross profit of 162.57M and revenue of 321.84M. Therefore, the gross margin over that period was 50.5%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

ARIS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Aris Water Solutions, Inc. reported an operating income of 157.69M and revenue of 321.84M, resulting in an operating margin of 49.0%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.

ARIS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Aris Water Solutions, Inc. reported a net income of 91.85M and revenue of 321.84M, resulting in a net margin of 28.5%.


Frequently Asked Questions


TGTX and ARIS have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ARIS has higher volatility (19.50%) compared to TGTX (12.23%). In terms of maximum drawdown, TGTX dropped -99.52% vs ARIS's -57.98%.

ARIS currently has the higher Sharpe Ratio (1.80 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TGTX and ARIS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer